Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93535711 | 9353571 | 1 | I | 20130603 | 0 | 20130617 | 20130617 | DIR | 43.00 | YR | F | N | 83.10000 | KG | 20130610 | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93535711 | 9353571 | 1 | PS | NULOJIX | 1 | INTRAVENOUS | D | D | 0 | 787.5 | MG | Q4W | |||||||
| 93535711 | 9353571 | 2 | SS | CELLCEPT | 1 | ORAL | D | D | 50722 | 1000 | MG | BID | |||||||
| 93535711 | 9353571 | 4 | C | ALEMTUZUMAB | 1 | 0 | |||||||||||||
| 93535711 | 9353571 | 6 | C | PREDNISONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93535711 | 9353571 | 1 | Renal transplant |
| 93535711 | 9353571 | 2 | Renal transplant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93535711 | 9353571 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93535711 | 9353571 | Pain in extremity | |
| 93535711 | 9353571 | Rash pustular | |
| 93535711 | 9353571 | Subcutaneous abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 93535711 | 9353571 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93535711 | 9353571 | 1 | 20130603 | 0 |